论文部分内容阅读
目的全面分析和研究子宫动脉栓塞术和米非司酮对治疗子宫肌瘤的临床效果。方法收集2010年3月至2011年8月期间来我院治疗的80例子宫肌瘤病患进行采访分析。在这80列病患中接受米非司酮医治的病患32例,接受子宫动脉栓塞术治疗的病患48例,对两种医治方法的疗效进行对比分析。结果两种治疗方法都能够对子宫肌瘤产生一定的抑制作用,有效提高临床症状的治疗,差异具有明显统计学意义。米非司酮组的患者比子宫动脉栓塞术组的患者体积缩小要明显,但是有复发的可能,子宫动脉栓塞术组的患者无复发现象。结论两种治疗方法都能够对子宫肌瘤产生一定的抑制作用,但是米非司酮治疗方法在停药后有复发的可能。子宫动脉栓塞术无复发效果较好,可推广应用。
Objective To comprehensively analyze and study the clinical effect of uterine arterial embolization and mifepristone on the treatment of uterine fibroids. Methods Eighty patients with uterine fibroids who were treated in our hospital from March 2010 to August 2011 were interviewed. Thirty-two patients receiving mifepristone and eighty-eight patients undergoing uterine arterial embolization were included in this study. The curative effects of the two methods were compared. The results of both treatment methods can have a certain inhibitory effect on uterine fibroids, effectively improve the clinical symptoms of treatment, the difference was statistically significant. Patients in the mifepristone group had a significantly smaller volume than patients in the uterine artery embolization group, but patients who received the uterine artery embolization had no recurrence. Conclusion Both treatments can inhibit uterine fibroids to a certain degree, but the treatment of mifepristone may have recurrence after discontinuation. Uterine artery embolization without recurrence is better, can be extended.